GE Medical barred from importing x-ray, radiation therapy systems from French facility.
This article was originally published in The Gray Sheet
GE BARRED FROM IMPORT OF X-RAY, RADIATION THERAPY DEVICES FROM FRENCH FACILITY due to good manufacturing practices deficiencies, FDA says in a June 12 warning letter. GE Medical, which ceased shipments of mammography and radiation therapy systems from the Buc Cedex, France facility on June 24, is working on correcting the deficiencies and plans to respond to the letter by July 3, the firm states. FDA's warning letter followed a Feb. 26-March 6 inspection of the plant.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.